| abstract |
Antibodies that specifically bind to CTLA-4 and / or PD-1 and antagonize CTLA-4 and / or PD-1 function are provided. Pharmaceutical compositions and kits containing these antibodies, nucleic acids encoding these antibodies, expression vectors and host cells for producing these antibodies, and any of these antibodies alone or in combination Methods for use in treating a subject are provided. |